Cart
sales@molnova.com
SBE 13 hydrochloride
CAS No. 1052532-15-6
SBE 13 hydrochloride ( SBE13; SBE 13; SBE13; SBE-13 HCl )
Catalog No. M17781 CAS No. 1052532-15-6
SBE13 hydrochloride is an effective and specific PLK1 inhibitor (IC50: 0.2 nM); no inhibition om Aurora A kinase, Plk2/3.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 43 | In Stock |
|
| 10MG | 71 | In Stock |
|
| 25MG | 141 | In Stock |
|
| 50MG | 267 | In Stock |
|
| 100MG | 399 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSBE 13 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionSBE13 hydrochloride is an effective and specific PLK1 inhibitor (IC50: 0.2 nM); no inhibition om Aurora A kinase, Plk2/3.
-
DescriptionSBE-13 is a selective inhibitor of PLK1 (IC50 values are 200 pM, 875 nM and 66 μ M for PLK1, PLK3 and PLK2 respectively).
-
SynonymsSBE13; SBE 13; SBE13; SBE-13 HCl
-
PathwayOthers
-
TargetOther Targets
-
RecptorPLK1; PLK2; PLK3
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1052532-15-6
-
Formula Weight479.4
-
Molecular FormulaC24H28Cl2N2O4
-
Purity98%
-
SolubilityDMSO : ≥ 42 mg/mL; 87.61 mM
-
SMILESClc1ncc(COc2c(OC)cc(CNCCc3cc(OC)c(OC)cc3)cc2)cc1.Cl
-
Chemical NameN-(4-((6-chloropyridin-3-yl)methoxy)-3-methoxybenzyl)-2-(3,4-dimethoxyphenyl)ethanamine hydrochloride
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Keppner S, et al. ChemMedChem. 2009 Nov;4(11):1806-9.2. Lange L, et al. Oncotarget. 2014 Apr 30;5(8):2263-75.
molnova catalog
related products
-
Cannabisin M
The herbs of Cannabis sativa L.
-
DOTA-?NHS-?ester
DOTA-NHS-ester is a linker for affibody molecules and is applied in small animals PET, SPECT, and CT. DOTA-NHS-ester can be used to label radiotherapeutic agents or imaging probes for the detection of tumors.
-
MS1943
MS1943 is a first-in-class, orally bioavailable EZH2 selective degrader, with an IC50 of 120 nM. MS1943 significantly reduces EZH2 protein levels in numerous triple-negative breast cancer (TNBC) and other cancer and noncancerous cell lines.
